Literature DB >> 25451188

Malignant insulinoma may arise during the course of type 1 diabetes mellitus: A case report.

S Lablanche1, M Chobert-Bakouline2, O Risse3, M-H Laverrière4, O Chabre2, P-Y Benhamou2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25451188     DOI： 10.1016/j.diabet.2014.08.004

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  4 in total

Review 1.  Case Report: Hypoglycemia Due to Metastatic Insulinoma in Insulin-Dependent Type 2 Diabetes Successfully Treated With 177 Lu-DOTATATE.

Authors:  Shejil Kumar; Mariah Melek; Peter Rohl
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-24       Impact factor: 6.055

2.  Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse.

Authors:  Hilde K Gjelberg; Dag Hoem; Caroline S Verbeke; Johan Eide; John G Cooper; Anders Molven
Journal:  Clin Case Rep       Date:  2017-04-06

3.  Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia.

Authors:  Marco Ciacciarelli; Gianluca Caruso; Marco Rengo; Piero Maceroni; Carmen Misurale; Eleonora D'Armiento; Alessandro Polidoro; Cristina Napoli; Alberto Lombardini; Umberto Ceratti; Ruben Manuel Luciano Colunga Biancatelli; Leonardo Calvosa; Romina Milanese; Sonia Ferri; Teresa Massaro; Andrea Lorusso; Veronica Sorrentino; Vincenzo Petrozza; Luigi Iuliano
Journal:  Case Rep Endocrinol       Date:  2020-01-31

Review 4.  Interplay Between Diabetes and Pancreatic Ductal Adenocarcinoma and Insulinoma: The Role of Aging, Genetic Factors, and Obesity.

Authors:  Bertrand Duvillié; Rayane Kourdoughli; Sabine Druillennec; Alain Eychène; Celio Pouponnot
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.